These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3949507)

  • 21. Use of tacrolimus ointment in vitiligo alone or in combination therapy.
    Berti S; Buggiani G; Lotti T
    Skin Therapy Lett; 2009 May; 14(4):5-7. PubMed ID: 19585060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of repigmentation in two cases of hypopigmented type of vitiligo.
    Anbar TS; El-Sawy AE; Attia SK; Moftah NH; El-Tonsy MH
    Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):156-8. PubMed ID: 19438996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial grafting for vitiligo requires ultraviolet A phototherapy to increase success rate.
    Awad SS; Abdel-Raof H; Hosam El-Din W; El-Domyati M
    J Cosmet Dermatol; 2007 Jun; 6(2):119-24. PubMed ID: 17524129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases.
    Silverberg NB; Lin P; Travis L; Farley-Li J; Mancini AJ; Wagner AM; Chamlin SL; Paller AS
    J Am Acad Dermatol; 2004 Nov; 51(5):760-6. PubMed ID: 15523355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Irreversible toxic depigmentation. Observations following use of hydroquinonemonobenzylether-containing skin bleaching preparations].
    Heilgemeir GP; Balda BR
    MMW Munch Med Wochenschr; 1981 Jan; 123(2):47-8. PubMed ID: 6782448
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W; Nieuweboer-Krobotova L
    Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on new and emerging options for the treatment of vitiligo.
    Mahmoud BH; Hexsel CL; Hamzavi IH
    Skin Therapy Lett; 2008 Mar; 13(2):1-6. PubMed ID: 18373041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
    Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
    J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
    Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Long-term effects of PUVA therapy on Israeli patients with vitiligo].
    Vussuki E; Ziv M; Rosenman D; David M
    Harefuah; 2006 Jul; 145(7):483-5, 552, 551. PubMed ID: 16900734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin.
    Abdel Naser MB; Wollina U; El Okby M; El Shiemy S
    Clin Exp Dermatol; 2004 Jul; 29(4):380-2. PubMed ID: 15245535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Satellite repigmentation after punch grafting.
    Agarwal US; Gulati R; Shukla SR; Mathur N
    Int J Dermatol; 2004 Apr; 43(4):273-4. PubMed ID: 15090010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo.
    Buckley DA; Rogers S
    Clin Exp Dermatol; 1996 Jan; 21(1):43-5. PubMed ID: 8689768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitiligo treated with topical clobetasol propionate.
    Kumari J
    Arch Dermatol; 1984 May; 120(5):631-5. PubMed ID: 6721525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical tacrolimus for treatment of childhood vitiligo in Asians.
    Kanwar AJ; Dogra S; Parsad D
    Clin Exp Dermatol; 2004 Nov; 29(6):589-92. PubMed ID: 15550128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study.
    Yalçin B; Sahin S; Bükülmez G; Karaduman A; Atakan N; Akan T; Kölemen F
    J Am Acad Dermatol; 2001 Apr; 44(4):634-7. PubMed ID: 11260538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitiligo therapy: where are we now?
    Arroyo MP; Tift L
    J Drugs Dermatol; 2003 Aug; 2(4):404-8. PubMed ID: 12884463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on skin repigmentation therapies in vitiligo.
    Falabella R; Barona MI
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depigmentation therapies for normal skin in vitiligo universalis.
    AlGhamdi KM; Kumar A
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.